| ［1］ |
Bsirini C, Smoller BR. Histologic mimics of malignant melanoma［J］. Singapore Med J, 2018,59（11）:602⁃607. doi: 10.11622/smedj.2018041.
|
| ［2］ |
Scalvenzi M, Costa C, De Fata Salvatores G, et al. Clinical and dermoscopic features of Spitz naevus by sex, age and anatomical site: a study of 913 Spitz naevi［J］. Br J Dermatol, 2018,179（3）:769⁃770. doi: 10.1111/bjd.16564.
|
| ［3］ |
Moscarella E, Lallas A, Kyrgidis A, et al. Clinical and dermoscopic features of atypical Spitz tumors: a multicenter, retrospective, case⁃control study［J］. J Am Acad Dermatol, 2015,73（5）:777⁃784. doi: 10.1016/j.jaad.2015.08.018.
|
| ［4］ |
Carrera C, Scope A, Dusza SW, et al. Clinical and dermoscopic characterization of pediatric and adolescent melanomas: multicenter study of 52 cases［J］. J Am Acad Dermatol, 2018, 78（2）:278⁃288. doi: 10.1016/j.jaad.2017.09.065.
|
| ［5］ |
Hillen LM, Vandyck H, Leunissen D, et al. Integrative histopathological and immunophenotypical characterisation of the inflammatory microenvironment in spitzoid melanocytic neoplasms［J］. Histopathology, 2021,78（4）:607⁃626. doi: 10.1111/his.14259.
|
| ［6］ |
刘芳, 王江潮, 刘宇, 等. Spitz样肿瘤320例临床及组织病理分析［J］. 中华皮肤科杂志, 2021,54（1）:33⁃41. doi: 10.35541/cjd.20200927.
|
| ［7］ |
Oaxaca G, Billings SD, Ko JS. p16 Range of expression in dermal predominant benign epithelioid and spindled nevi and melanoma［J］. J Cutan Pathol, 2020,47（9）:815⁃823. doi: 10.1111/cup.13721.
|
| ［8］ |
DiSano K, Tschen JA, Cho⁃Vega JH. Intratumoral heterogeneity of chromosome 9 loss and CDKN2A （p16） protein expression in a morphologically challenging spitzoid melanoma［J］. Am J Dermatopathol, 2013,35（2）:277⁃280. doi: 10.1097/DAD.0b013 e31826b187b.
|
| ［9］ |
McNeal AS, Liu K, Nakhate V, et al. CDKN2B loss promotes progression from benign melanocytic nevus to melanoma［J］. Cancer Discov, 2015,5（10）:1072⁃1085. doi: 10.1158/2159⁃8290. CD⁃15⁃0196.
|
| ［10］ |
Ma SA, O′Day CP, Dentchev T, et al. Expression of p15 in a spectrum of spitzoid melanocytic neoplasms［J］. J Cutan Pathol, 2019,46（5）:310⁃316. doi: 10.1111/cup.13424.
|
| ［11］ |
Kapur P, Selim MA, Roy LC, et al. Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohistochemical analysis［J］. Mod Pathol, 2005,18（2）:197⁃204. doi: 10.1038/modpathol.3800 281.
|
| ［12］ |
Torres⁃Cabala C, Li⁃Ning⁃Tapia E, Hwu WJ. Pathology⁃based biomarkers useful for clinical decisions in melanoma［J］. Arch Med Res, 2020,51（8）:827⁃838. doi: 10.1016/j.arcmed.2020.09. 008.
|
| ［13］ |
Vyas NS, Charifa A, Desman GT, et al. Observational study examining the diagnostic practice of Ki67 staining for melanocytic lesions［J］. Am J Dermatopathol, 2019,41（7）:488⁃491. doi: 10.1097/DAD.0000000000001379.
|
| ［14］ |
王艳青, 郭莹. Spitz痣的病理特点及诊断［J］. 中华皮肤科杂志, 2021,54（4）:308⁃312. doi: 10.35541/cjd.20200841.
|
| ［15］ |
Guanziroli E, Del Gobbo A, Coggi A, et al. Nestin expression in spitzoid lesions: an immunohistochemical characterization with clinical and dermoscopic correlations0［J］. Appl Immunohistochem Mol Morphol, 2019,27（6）:430⁃435. doi: 10.1097/PAI.0000000000000653.
|
| ［16］ |
Garola R, Singh V. Utility of p16⁃Ki⁃67⁃HMB45 score in sorting benign from malignant Spitz tumors［J］. Pathol Res Pract, 2019,215（10）:152550. doi: 10.1016/j.prp.2019.152550.
|
| ［17］ |
Wiedemeyer K, Guadagno A, Davey J, et al. Acral Spitz nevi: a clinicopathologic study of 50 cases with immunohistochemical analysis of P16 and P21 expression［J］. Am J Surg Pathol, 2018,42（6）:821⁃827. doi: 10.1097/PAS.0000000000001051.
|
| ［18］ |
Gerami P, Jewell SS, Morrison LE, et al. Fluorescence in situ hybridization （FISH） as an ancillary diagnostic tool in the diagnosis of melanoma［J］. Am J Surg Pathol, 2009,33（8）:1146⁃1156. doi: 10.1097/PAS.0b013e3181a1ef36.
|
| ［19］ |
Gammon B, Beilfuss B, Guitart J, et al. Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe［J］. Am J Surg Pathol, 2012,36（1）:81⁃88. doi: 10.1097/PAS.0b013e31822d5ff8.
|
| ［20］ |
Gerami P, Li G, Pouryazdanparast P, et al. A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms［J］. Am J Surg Pathol, 2012,36（6）:808⁃817. doi: 10.1097/PAS.0b013e31824b1efd.
|
| ［21］ |
Gerami P, Scolyer RA, Xu X, et al. Risk assessment for atypical spitzoid melanocytic neoplasms using FISH to identify chromosomal copy number aberrations［J］. Am J Surg Pathol, 2013,37（5）:676⁃684. doi: 10.1097/PAS.0b013e3182753de6.
|
| ［22］ |
Yazdan P, Cooper C, Sholl LM, et al. Comparative analysis of atypical Spitz tumors with heterozygous versus homozygous 9p21 deletions for clinical outcomes, histomorphology, BRAF mutation, and p16 expression［J］. Am J Surg Pathol, 2014,38（5）:638⁃645. doi: 10.1097/PAS.0000000000000160.
|
| ［23］ |
Shao L, Akkari Y, Cooley LD, et al. Chromosomal microarray analysis, including constitutional and neoplastic disease applications, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics （ACMG）［J/OL］. Genet Med, 2021［2021⁃06⁃28］. doi: 10.1038/s41436⁃021⁃01214⁃w. https://www.nature.com/articles/s41436⁃021⁃01214⁃w.
|
| ［24］ |
Wiesner T, He J, Yelensky R, et al. Kinase fusions are frequent in Spitz tumours and spitzoid melanomas［J］. Nat Commun, 2014,5:3116. doi: 10.1038/ncomms4116.
|
| ［25］ |
Quan VL, Zhang B, Zhang Y, et al. Integrating next⁃generation sequencing with morphology improves prognostic and biologic classification of Spitz neoplasms［J］. J Invest Dermatol, 2020,140（8）:1599⁃1608. doi: 10.1016/j.jid.2019.12.031.
|
| ［26］ |
de la Fouchardière A, Tee MK, Peternel S, et al. Fusion partners of NTRK3 affect subcellular localization of the fusion kinase and cytomorphology of melanocytes［J］. Mod Pathol, 2021,34（4）:735⁃747. doi: 10.1038/s41379⁃020⁃00678⁃6.
|
| ［27］ |
Houlier A, Pissaloux D, Masse I, et al. Melanocytic tumors with MAP3K8 fusions: report of 33 cases with morphological⁃genetic correlations［J］. Mod Pathol, 2020,33（5）:846⁃857. doi: 10.1038/s41379⁃019⁃0384⁃8.
|
| ［28］ |
Amin SM, Haugh AM, Lee CY, et al. A comparison of morphologic and molecular features of BRAF, ALK, and NTRK1 fusion spitzoid neoplasms［J］. Am J Surg Pathol, 2017,41（4）:491⁃498. doi: 10.1097/PAS.0000000000000761.
|
| ［29］ |
任静, 任敏, 孔蕴毅, 等. 间变性淋巴瘤激酶阳性的Spitz肿瘤临床病理学特征及预后［J］. 中华病理学杂志,2019,48（3）: 215⁃219. doi: 10.3760/cma.j.issn.0529⁃5807.2019.03.009.
|
| ［30］ |
Ritter A, Tronnier M, Vaske B, et al. Reevaluation of established and new criteria in differential diagnosis of Spitz nevus and melanoma［J］. Arch Dermatol Res, 2018,310（4）:329⁃342. doi: 10.1007/s00403⁃018⁃1818⁃8.
|
| ［31］ |
Cho⁃Vega JH. A diagnostic algorithm for atypical spitzoid tumors: guidelines for immunohistochemical and molecular assessment［J］. Mod Pathol, 2016,29（7）:656⁃670. doi: 10.1038/modpathol.2016.70.
|
